Advanced Solid Tumors: SNV1521 Treatment Study

We are exploring a new treatment called SNV1521 for individuals with advanced solid tumors. This study aims to determine the safety and appropriate dosage of this medication.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut De Cancerologie De L Ouest
Medical
Avignon, France
Institut Bergonie
Medical Oncology
Bordeaux, France
Institut Paoli Calmettes
Oncology
Marseille, France

Sponsor: Synnovation Therapeutics Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.